- •Foreword
- •Preface
- •Contents
- •1.1 Introduction
- •1.2 Method
- •1.2.1 Databases
- •1.2.2 Dates
- •1.2.3 Keywords
- •1.2.4 Criteria for Inclusion
- •1.2.5 Criteria for Exclusion
- •1.2.6 Selection of Papers
- •1.3 Results
- •1.3.1 Subspecialty
- •1.3.2 Type of Telemedicine
- •1.3.3 Study Design
- •1.3.4 Final Conclusions of Papers
- •1.4 Discussion
- •References
- •2.1 Introduction
- •2.2 The Need for Diabetic Retinopathy Screening Programs
- •2.4 Guidelines for Referring Patients
- •2.7 Program Models for Diabetic Retinopathy Screening
- •2.9 Program Personnel and Operations
- •2.9.1 Primary Care Providers
- •2.9.2 Photographers
- •2.9.3 Clinical Consultants
- •2.9.4 Administrators
- •2.9.5 A Note to CEOs, Operations Directors, and Clinic Managers
- •2.10 Policies and Procedures
- •2.10.1 Sample Protocol 1
- •2.10.1.1 Diabetic Retinopathy Screening Services
- •Policy
- •Background
- •Procedure
- •2.10.2 Sample Protocol 2
- •2.10.2.1 Pupil Dilation Before Diabetic Retinopathy Photography
- •Policy
- •Background
- •Procedure
- •2.10.3 Sample Protocol 3
- •2.10.3.1 Diabetic Retinopathy Photography Review
- •Policy
- •Background
- •Procedure
- •2.11 Technical Requirements
- •2.11.1 Connectivity
- •2.11.2 Resolution
- •2.11.3 Color
- •2.11.4 Stereopsis
- •2.11.5 Compression
- •2.11.6 Enhancement
- •2.11.7 Pupil Dilation
- •2.11.8 Early California Telemedicine Initiatives Diabetic Retinopathy Screening
- •2.11.9 The American Indian Diabetes Teleophthalmology Grant Program
- •2.11.10 Central Valley EyePACS Diabetic Retinopathy Screening Project
- •2.12.1 Diabetic Retinopathy
- •2.12.1.1 ADA Guidelines Terms
- •2.12.1.2 Vitrectomy
- •References
- •3: Stereopsis and Teleophthalmology
- •3.1 Introduction
- •3.2 History of Stereopsis and Stereopsis in Ophthalmology
- •3.3 Technology and Photography
- •3.3.3 Imaging Fields
- •3.3.4 Image Viewing Techniques
- •3.3.5 Image Compression
- •3.4 Stereoscopic Teleophthalmology Systems
- •3.4.1 University of Alberta
- •3.4.4 Joslin Vision Network
- •3.5 Conclusion
- •References
- •4.1 Introduction
- •4.2 Methods
- •4.2.1 Main Outcome Measures
- •4.3 Results
- •4.3.1 Retinal Video Recording Versus Retinal Still Photography
- •4.3.2 Video Compression Analysis
- •4.4 Discussion
- •References
- •5.1 Introduction
- •5.1.1 Automated, Remote Image Analysis of Retinal Diseases
- •5.1.2 Telehealth
- •5.2 Design Requirements
- •5.2.1 Telehealth Network Architecture
- •5.2.2 Work Flow
- •5.2.3 Performance Evaluation of the Network
- •5.3 Automated Image Analysis Overview
- •5.3.1 Quality Assessment Module
- •5.3.2 Vascular Tree Segmentation
- •5.3.3 Quality Evaluation
- •5.4 Anatomic Structure Segmentation
- •5.4.1 Optic Nerve Detection
- •5.4.2 Macula
- •5.4.3 Lesion Segmentation
- •5.4.4 Lesion Population Description
- •5.4.5 Image Query
- •5.5 Summary
- •References
- •6.1 Introduction
- •6.3 Optical Coherence Tomography to Detect Leakage
- •References
- •7.1 Introduction
- •7.2 Patients and Methods
- •7.2.1 Participants
- •7.2.2 Methods
- •7.2.3 Statistics
- •7.3 Results
- •7.3.1 Reliability of Image Evaluation
- •7.3.2 Prevalence of Glaucomatous Optic Nerve Atrophy
- •7.4 Discussion
- •7.5 Perspectives
- •References
- •8.1 Introduction
- •8.1.2 Homology Between Retinal and Systemic Microvasculature
- •8.1.3 Need for More Precise CVD Risk Prediction
- •8.2.1 Retinal Microvascular Signs
- •8.2.2 Retinal Vessel Biometry
- •8.2.3 Newer Retinal Imaging for Morphologic Features of Retinal Vasculature
- •8.3 Associations of Retinal Imaging and CVD Risk
- •8.3.1.1 Risk of Pre-clinical CVD
- •8.3.1.2 Risk of Stroke
- •8.3.1.3 Risk of Coronary Heart Disease
- •8.3.2.1 Risk of Hypertension
- •8.3.2.2 Risk of Stroke
- •8.3.2.3 Risk of Coronary Heart Disease
- •8.3.2.4 Risk of Peripheral Artery Disease
- •8.3.3 Newer Morphologic Features of Retinal Vasculature
- •8.4 Retinal Imaging and Its Potential as a Tool for CVD Risk Prediction
- •References
- •9.1 Alzheimer’s Disease
- •9.2 Treatments
- •9.3 Diagnosis
- •9.6 Conclusions
- •References
- •10.1 Introduction
- •10.1.1 Stroke
- •10.1.2 Heart Disease
- •10.1.3 Arteriovenous Ratio
- •10.2 Purpose
- •10.3 Method
- •10.3.1 Medical Approach
- •10.3.2 Technical Approach
- •10.3.3 Output of Medical Data
- •10.4 Patients
- •10.5 Results
- •10.5.1 Medical History
- •10.5.2 Telemedical Evaluation of Retinal Vessels
- •10.5.2.1 Prevalence of Retinal Microangiopathy
- •10.5.2.2 Arteriovenous Ratio
- •10.5.2.3 PROCAM-Index
- •10.6 Discussion and Perceptive
- •10.6.1 Estimation of “Stroke Risk” Estimated by the Stage of Retinal Microangiopathy
- •References
- •11.1 Introduction
- •11.2 System Requirements
- •11.3 Fundus Camera
- •11.4 Imaging Procedure
- •11.4.1 Reading Center Procedure
- •11.5 Detection of Macular Edema
- •11.6 Implementation
- •11.7 Unreadable Images
- •11.7.1 Impact on Overall Diabetic Retinopathy Assessment Rates
- •11.7.2 Compliance with Recommendations
- •11.7.3 Challenges
- •11.7.4 Summary
- •References
- •12.1 Screening
- •12.2 Background
- •12.3 Historical Perspective in England
- •12.4 Methodology
- •12.4.1 The Aim of the Programme
- •12.5 Systematic DR Screening
- •12.6 Cameras for Use in the English Screening Programme
- •12.7 Software for Use in the English Screening Programme
- •12.9 Implementation in England
- •12.11 Quality Assurance
- •12.12 The Development of External Quality Assurance in the English Screening Programme
- •12.13 Information Technology (IT) Developments for the English Screening Programme
- •12.14 Dataset Development
- •12.15 The Development of External Quality Assurance Test Set for the English Screening Programme
- •12.16 Failsafe
- •12.17 The Epidemic of Diabetes
- •References
- •13.1 Introduction
- •13.2 Burden of Diabetes and Diabetic Retinopathy in India
- •13.3 Diabetic Retinopathy Screening Models
- •13.4 Need for Telescreening
- •13.5 Guidelines for Telescreening
- •13.6 ATA Categories of DR Telescreening Validation
- •13.7 Yield of Diabetic Retinopathy in a Telescreening Model
- •13.8 How Are Images Transferred
- •13.10 How Many Fields Are Enough for Diabetic Retinopathy Screening
- •13.11 Is Mydriasis Needed While Using Nonmydriatic Camera?
- •13.12 Validation Studies on Telescreening
- •13.12.1 Accuracy of Telescreening
- •13.12.2 Patient Satisfaction in Telescreening
- •13.12.3 Cost Effectivity
- •13.12.4 Telescreening for Diabetic Retinopathy: Our Experience
- •13.13 Future of Diabetic Retinopathy Screening
- •References
- •14.1 Introduction
- •14.2 Methods
- •14.3 Discussion
- •14.4 Conclusion
- •References
- •15.1 Introduction
- •15.1.1 Description of the EADRSI
- •15.5 State Support of Screening in the Safety Net
- •15.7 Screening Economics for Providers
- •15.8 Patient Sensitivity to Fees
- •15.9 Conclusion
- •References
- •16.1 Introduction
- •16.2 Setting Up the New Screening Model
- •16.2.1 Phase 1: Training
- •16.2.2 Phase 2: Evaluation of Agreement
- •16.2.3 Phase 3: Implementation of the Screening Model
- •16.3 Technologic Requirements
- •16.3.1 Data Management
- •16.3.2 Data Models
- •16.3.2.1 Data Scheme for Patient-Related Information
- •16.3.2.2 Data Scheme for Images
- •Fundus Camera VISUCAM Pro NM
- •PACS Server
- •ClearCanvas DICOM Visualizer
- •16.4 Results
- •16.4.1 Phase 2: Agreement Evaluation
- •16.4.2 Phase 3: Implementation of the Screening Model
- •16.5 Discussion
- •16.5.1 Evaluation of the Screening Model
- •16.5.2 Prevalence of DR
- •16.5.3 Quality Evaluation
- •16.6 Conclusion
- •References
- •17.1.3 Examination and Treatment
- •17.1.4 Limitations of Current Care
- •17.2 Telemedicine and ROP
- •17.2.2 Accuracy and Reliability of Telemedicine for ROP Diagnosis
- •17.2.3 Operational ROP Telemedicine Systems
- •17.2.4 Potential Barriers
- •17.3 Closing Remarks
- •17.3.1 Future Directions
- •References
- •18.1 Introduction
- •18.2 Neonatal Stress and Pain
- •18.3 ROP Screening Technique
- •18.4 Effect of Different Examination Techniques on Stress
- •18.5 Future of Retinal Imaging in Babies
- •References
- •19.1 Introduction
- •19.2 History of the Program
- •19.3 Telehealth Technologies
- •19.4 Impact of the Program
- •Selected References
- •Preamble
- •Introduction
- •Background
- •The Diabetic Retinopathy Study (DRS)
- •Mission
- •Vision
- •Goals
- •Guiding Principles
- •Ethics
- •Clinical Validation
- •Category 1
- •Category 2
- •Category 3
- •Category 4
- •Communication
- •Medical Care Supervision
- •Patient Care Coordinator
- •Image Acquisition
- •Image Review and Evaluation
- •Information Systems
- •Interoperability
- •Image Acquisition
- •Compression
- •Data Communication and Transmission
- •Computer Display
- •Archiving and Retrieval
- •Security
- •Reliability and Redundancy
- •Documentation
- •Image Analysis
- •Legal Requirements
- •Facility Accreditation
- •Privileging and Credentialing
- •Stark Act and Self-referrals
- •State Medical Practice Acts/Licensure
- •Tort Liability
- •Duty
- •Standards of Care
- •Consent
- •Quality Control
- •Operations
- •Customer Support
- •Originating Site
- •Transmission
- •Distant Site
- •Financial Factors
- •Reimbursement
- •Grants
- •Federal Programs
- •Other Financial Factors
- •Equipment Cost
- •Summary
- •Abbreviations
- •Appendices
- •Appendix A: Interoperability
- •Appendix B: DICOM Metadata
- •Appendix C: Computer-Aided Detection
- •Appendix D: Health Insurance Portability and Accountability Act (HIPAA)
- •Appendix F: Quality Control
- •Appendix H: Customer Support
- •Level 1
- •Level 2
- •Level 3
- •Appendix I: Reimbursement
- •Medicare
- •Medicaid
- •Commercial Insurance Carrier Reimbursement
- •Other Financial Factors
- •Disease Prevention
- •Resource Utilization
- •American Telemedicine Association’s Telehealth Practice Recommendations for Diabetic Retinopathy
- •Conclusion
- •References
- •Contributors
- •Second Edition
- •First Edition
- •Index
48 |
T.P. Karnowski et al. |
|
|
The server web GUI provides an interface for authorized access of the diagnostic result. For the consulting ophthalmologist, the diagnostic result, together with the images and patient metadata, is reviewed through the web GUI for confirmed digital signature, encryption, and report to the referring physician. For a referring physician, the web GUI provides a secure access to the diagnostic result along with patient information. The server web GUI can be accessed through fixed or mobile electronic devices, provided that it has browser access to the web.
The encrypted PDF report contains patient metadata, the fundus image from both eyes, the diagnosis, and recommendation plan, encrypted and electronically signed by a consulting ophthalmologist. The report can either be accessed by an authorized user through the web GUI, or as a password-protected e-mail attachment for the referring physician.
5.2.3Performance Evaluation of the Network
Rapid data transmission and high throughput is one of the key features of the telemedical network. To validate the performance of the designed network infrastructure, the average time from image acquisition to report generation is applied as a metric for performance evaluation. The following system response time is measured by observing 60 sessions of data transmission between a fundus camera in an active clinic and the diagnostic server. In our implementation of the diagnostic network, we provide the ophthalmologist with the ability to manually assign a diagnosis before the automatic diagnosis engine is fully incorporated into the system. In the experiment, we estimated that the automatic diagnosis can be assigned within 20 s. The average time frame for each processing step is shown in the following table. A conservative estimation of the average response time from image acquisition to the generation of a diagnostic and management report for the end user is less than 2 min (Table 5.1). The network structure provides sufficiently high throughput for image analysis and diagnosis of diabetic eye disease [13].
Table 5.1 System response time in a real clinic setting
Process |
Response time (s) |
Export image |
10.60 ± 0.61 |
Encryption and transmission |
29.78 ± 1.57 |
of images for both eyes |
|
Validate metadata and image |
8.41 ± 0.82 |
data consistency |
|
Image quality assurance check |
1.72 ± 0.45 |
Feedback to the camera |
4.18 ± 0.62 |
Load into database |
1.20 ± 0.38 |
Estimated automatic diagnosis |
20.00 ± 0.10 |
Generate report |
11.98 ± 1.18 |
Total |
87.88 ± 2.37 |
5.3Automated Image Analysis Overview
Our research in automated image analysis for ophthalmology pertains broadly to telemedical applications and intelligent systems for automated or semiautomated screening. In the former case, even when no automatic disease assessment is attempted, there is a requirement for image analysis to assess the quality of submitted images. In the latter case, we note, there has been active research in automated retina screening for some time (see review in [14]). Broadly, image processing and analysis of fundus images consist of defining the anatomical location (isolating the vessels, optic nerve, and macula) and identifying the pathology of the retina through segmentation of lesions such as microaneurysms and exudates.
In our research, we perform these basic steps, grouped into functional modules, as shown in Fig. 5.2. The first processing block, quality estimation, utilizes vessel segmentation as well as machine learning techniques. Images of sufficient quality and related exam information are saved in a database for physician diagnosis.
Our method features a parallel processing flow for computer diagnosis of the retina images. The anatomic structures (optic nerve and macula) are located using properties of the vessel segmentation and an optic nerve location algorithm described below. The lesion detection focuses currently on microaneurysms and exudates, the major features of diabetic retinopathy. The lesion population description module computes
5 Automated Image Analysis and the Application of Diagnostic Algorithms in an Ocular Telehealth Network 49
Quality estimation Anatomic location Lesion detection
ELVD
Lesion population |
Image retrieval |
Fig. 5.2 Functional modules for retinal image management, feature extraction, and diagnostic assignment using CBIR. Quality estimation is performed, and images of sufficient quality are submitted to the system for anatomic localization of the optic nerve and macula. Lesion detection
is then performed, characterized, and submitted to the image library as an image retrieval, where similar images are found in the database and their corresponding diagnosis used to estimate the disease state of the query image
numerical descriptors of the detected lesion popu- |
the image quality is sufficient to determine a level |
lation which are mathematically transformed into |
of disease, the clinician may still opt to pass it to |
a compact, lower-dimensional subspace suited for |
the database with qualifications. These images |
image indexing and retrieval. Finally, this compact |
would not undergo the automated processing |
description is utilized in the image query block, |
path; instead, they would be passed directly to the |
where our system can search through hundreds |
oversight physician for review. |
of thousands of examples using CBIR methodol- |
In the remainder of this section, we cover the |
ogy to obtain rough matches to the lesion popu- |
functional blocks, starting with the quality assess- |
lation description. These rough matches are then |
ment module (and including vessel segmentation, |
searched using distance metrics based on the |
the key metric for our quality estimation method) |
individual population descriptions to obtain an |
and continuing with the anatomic structures, |
estimate of the disease state of the retina. Finally, |
lesion detection, lesion population, and image |
a report is generated for physician review and |
query blocks. |
perhaps ultimately completely automated disease |
|
assessment. |
|
Throughout the system, confidence measure- |
5.3.1 Quality Assessment Module |
ments are attached to the processing which can |
|
be used to invoke “physician oversight,” a key |
While various methods have been proposed to |
procedure where the automated processing rec- |
assess retina image quality [15, 16, 17, 18], in our |
ognition system identifies images where com- |
application, we found that most methods were |
plete automation has limitations. For example, if |
computationally too expensive since our assess- |
the quality assessment module fails an image but |
ment is designed to be performed in near real |
50 |
T.P. Karnowski et al. |
|
|
NO (retake image)
|
|
|
|
|
|
Pattern |
Quality > |
|
|
|
|
|
|
||
|
|
|
|
|
|
classifier |
Threshold |
|
|
|
|
|
|
|
|
YES
(submit
image)
Fig. 5.3 Quality estimator. The vascular tree of the image is segmented, and the color of the original image is measured using an RGB histogram. The vessel density within the annular/wedge regions is measured and passed to a pattern classifier function which produces a numeric
measurement of the similarity between the submitted image and a library of good examples. Submissions that are above a threshold are deemed “good” quality and are entered into the network for review
time in the primary care setting so that inadequate images may be retaken. Therefore, we required a fast method for timely feedback to the camera operator, with computational constraints of a standard personal computer such as that used in fundus camera platforms. Our development work here is summarized, but more detail is available in [19] and [20]. Broadly, the assessment consists of segmenting the vessel structure, saving this result for subsequent processing, then estimating the quality based on the vessel structure and fundus color.
example [21–25], with a comparison of methods using a public database with hand-segmented data published in [26]. The study found that all reviewed methods performed reasonably well, with the method of [24] virtually identical to that of the second observer. However, several methods scored almost as well, and in our work, we implemented the method described in [27, 28] which uses morphological reconstruction elements to estimate the vascular tree. Our implementation in the telemedical network is fairly fast, with a mean time estimate of less than 1 s while running on a 1.66 GHz Intel-based PC server.
5.3.2Vascular Tree Segmentation
Vessel segmentation is important in general for three main reasons: some ocular diseases (e.g., retinal vein occlusions) may be diagnosed through analysis of the vascular tree; the distinct characteristics of the vessels can provide landmarks for registration of multiple images of the same retina (e.g., for applications in fluorescein angiography); and finally, the vessels assist in locating the optic nerve and fovea. In our system, we add a fourth reason: quality assessment, since generally, good quality images will have a well-defined vessel structure. Consequently, there has been much research on vessel segmentation for retina images and in medical imaging in general, for
5.3.3Quality Evaluation
In the actual quality evaluation, the vascular image is divided into annular and wedge-shaped regions which are then used to estimate the coverage of the vascular tree. This process is summarized in Fig. 5.3. Images which do not achieve adequate coverage in some regions will be regarded as an outlier by the machine learning system (or classifier) and will fail the quality assessment. In addition, the color of the fundus is measured by using a histogram of the RGB values. The region coverage and color measurements are then combined into a single feature vector. During initial development, a set of images from the telemedical
